Founded in 2014 by a visionary team comprising Vinayak Nandalike, Ram Mohan Rao, Dr. Sanjay Sharma, and Maruthy K N, Yostra Labs has emerged as a significant player in the healthcare technology sector.
With its headquarters in Bengaluru, Yostra Labs is dedicated to transforming diabetic foot care through innovative, accessible, and sustainable solutions.
The Challenge of Diabetic Foot Complications
Diabetes has reached epidemic proportions globally, with millions of individuals affected by its complications, especially diabetic foot ulcers (DFUs).
These ulcers can lead to severe consequences, including infections, amputations, and even fatalities if not treated promptly and effectively.
The World Health Organization estimates that approximately 15% of diabetic patients will develop a foot ulcer in their lifetime, a staggering statistic that underscores the urgent need for effective intervention.
Despite advancements in medical science, the accessibility and affordability of diagnostic and treatment options for diabetic foot conditions remain significant hurdles, particularly in developing markets.
Patients often face delays in diagnosis and treatment, leading to worsened health outcomes.
Recognizing this pressing issue, Yostra Labs set out on a mission to enhance diabetic foot care through smart and practical solutions.
The Journey of Yostra Labs
From its inception, Yostra Labs has been committed to developing innovative healthcare technologies tailored for cost-sensitive markets.
The founders, equipped with a diverse background in engineering, medicine, and design, harnessed their expertise to create devices that prioritize accessibility without compromising quality.
Their flagship product, NEURO TOUCH, is a groundbreaking 5-in-1 multi-parameter device designed for the assessment and screening of peripheral neuropathy.
By evaluating both small and large nerve fibers, NEURO TOUCH empowers healthcare professionals to diagnose and monitor neuropathic conditions with unprecedented ease.
The device features cloud-based AI report generation, Bluetooth data transfer, and remote access to reports through an Android/iOS app and web portal.
Remarkably portable at just 470 grams, NEURO TOUCH can screen 30 to 50 patients on a single charge, making it an invaluable tool for clinics and home care settings alike.
In addition to NEURO TOUCH, Yostra Labs introduced VELOX CARE, an advanced wound healing device that employs warm oxygen therapy to accelerate the healing process of chronic wounds.
By enhancing blood circulation and oxygenation, VELOX CARE significantly improves wound healing outcomes, a critical factor for diabetic patients.
The device’s user-friendly design ensures it can be effectively utilized in both clinical and home environments.
Lastly, the NEURO KIT provides a comprehensive approach to early detection and assessment of peripheral neuropathy.
Comprising three essential diagnostic tools—NEURO CHECK for vibration perception, NEURO THERM for temperature sensation testing, and a 10g Monofilament for touch sensation—the NEURO KIT equips healthcare professionals with the means to effectively screen and monitor neuropathy, facilitating timely intervention.
Impact and Reach
Since its founding, Yostra Labs has successfully conducted over 200,000 assessments and installed more than 1,750 devices across India.
The team at Yostra Labs consists of clinicians, designers, and engineers who collaborate to continually innovate and improve their offerings.
This multidisciplinary approach not only fosters creativity but also ensures that the products developed meet the real needs of patients and healthcare providers.
The commitment to addressing critical healthcare challenges has garnered attention on both national and global platforms, with Yostra Labs presenting its findings and innovations at various international healthcare conferences.
Looking Ahead
As Yostra Labs continues to expand its reach and refine its products, the focus remains on creating impactful solutions that enhance the quality of life for diabetic patients.
The company is actively exploring partnerships with healthcare institutions and NGOs to further its mission of making diabetic foot care accessible to underserved populations.
Yostra Labs also plans to invest in research and development to expand its product line, incorporating the latest advancements in technology and patient care practices.
With a decade of trusted presence and a steadfast commitment to innovation, Yostra Labs is poised to revolutionize diabetic foot care, making a meaningful difference in the lives of countless individuals facing the challenges of diabetes.
